Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2013 02:13 ET | Source: Photocure ASA

Photocure ASA : Tilbakekjøpsprogram for aksjer

Oslo, 10. januar 2013 I ordinær generalforsamling 10. mai 2012 fikk styret i Photocure ASA fullmakt til å erverve egne aksjer i forbindelse med ordning for ansattes kjøp av aksjer i selskapet....
January 10, 2013 02:13 ET | Source: Photocure ASA

Photocure ASA : Repurchase program of own shares

Oslo, Norway, 10 January 2013 According to the resolution made by the Annual General Meeting on 10 May 2012, the Board of Directors of Photocure ASA was given Power of Attorney to acquire own shares...
January 09, 2013 08:53 ET | Source: Photocure ASA

Photocure ASA:Finanskalender 2013

Oslo, 9. januar 2013 Photocure ASA vil avholde kvartalspresentasjoner og ordinær generalforsamling på følgende datoer i 2013: 28. februar 2013 - Presentasjon av resultatrapport for fjerde kvartal...
January 09, 2013 08:53 ET | Source: Photocure ASA

Photocure ASA: Financial Calendar 2013

Oslo, Norway, 9 January 2013 Photocure ASA presents its financial calendar for 2013: 28 February 2013 - Presentation of the fourth quarter and full year 2012 26 April 2013 - Presentation of the...
January 02, 2013 02:30 ET | Source: Photocure ASA

PHOTOCURE HAR MOTTATT MILEPÆLSBETALING FOR LUMACAN®

Oslo, 2. januar 2013: Photocure ASA (OSE: PHO), et farmasøytisk selskap som spesialiserer seg innen fotodynamisk teknologi for dermatologi og kreft, har mottatt USD 4,5 millioner i milepælsbetaling...
January 02, 2013 02:30 ET | Source: Photocure ASA

PHOTOCURE ANNOUNCES PAYMENT RECEIVED FOR LUMACAN® DEVELOPMENT

Oslo, Norway, January 2, 2012: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today that it has received a...
December 05, 2012 08:55 ET | Source: Photocure ASA

Presentasjon av Cevira® fase 2b resultater

Oslo, 5. desember 2012 Photocure inviterer til audio webcast i dag kl 15:00 for å presentere resultatene fra Cevira fase 2b studien. Du kan følge presentasjonen via denne linken:...
December 05, 2012 08:55 ET | Source: Photocure ASA

Presentation of Cevira® Phase 2b Results

Oslo, Norway, 5 December 2012 Photocure will host an audio webcast today at 15.00 CET / 14.00 GMT / 09.00 EST to present the Cevira phase 2b results. It will be possible to follow the presentation...
December 05, 2012 02:30 ET | Source: Photocure ASA

PHOTOCURE OFFENTLIGGJØR POSITIVE RESULTATER FRA CEVIRA® STUDIE

RESULTATENE VISER SIGNIFIKANTE RESULTATER I BEHANDLING AV LESJONER OG KREFTRELATERT HUMAN PAPILLOMAVIRUS (HPV) HOS PASIENTER MED FORSTADIER TIL LIVMORHALSKREFT Oslo, 5. desember 2012: Photocure ASA...
December 05, 2012 02:30 ET | Source: Photocure ASA

PHOTOCURE ANNOUNCES POSITIVE RESULTS OF CEVIRA® STUDY

RESULTS DEMONSTRATE SIGNIFICANT EFFICACY IN TREATMENT OF LESIONS AND ONCOGENIC HUMAN PAPILLOMA VIRUS IN PATIENTS WITH PRECANCEROUS LESIONS OF THE CERVIX Oslo, Norway, December 5, 2012: Photocure ASA...